Oderda GM - Search Results

1

The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.

Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI. Joish VN, et al. Among authors: oderda gm. Curr Med Res Opin. 2005 Apr;21(4):535-44. doi: 10.1185/030079905X38240. Curr Med Res Opin. 2005. PMID: 15899102

2

Cost-utility analysis and quality adjusted life years.

Joish VN, Oderda GM. Joish VN, et al. Among authors: oderda gm. J Pain Palliat Care Pharmacother. 2005;19(1):57-61. J Pain Palliat Care Pharmacother. 2005. PMID: 15814516 Review.

3

Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices.

Brixner DI, Oderda GM, Nickman NA, Beveridge R, Jorgenson JA. Brixner DI, et al. Among authors: oderda gm. J Natl Compr Canc Netw. 2006 Mar;4(3):197-208. doi: 10.6004/jnccn.2006.0020. J Natl Compr Canc Netw. 2006. PMID: 16507268

4

Naturalistic impact of second-generation antipsychotics on weight gain.

Brixner DI, Said Q, Corey-Lisle PK, Tuomari AV, L'italien GJ, Stockdale W, Oderda GM. Brixner DI, et al. Among authors: oderda gm. Ann Pharmacother. 2006 Apr;40(4):626-32. doi: 10.1345/aph.1G564. Epub 2006 Mar 28. Ann Pharmacother. 2006. PMID: 16569802

5

Opioid expenditures and utilization in the Medicaid system.

Brixner DI, Oderda GM, Roland CL, Rublee DA. Brixner DI, et al. Among authors: oderda gm. J Pain Palliat Care Pharmacother. 2006;20(1):5-13. J Pain Palliat Care Pharmacother. 2006. PMID: 16687350

6

Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin.

LaFleur J, Thompson CJ, Joish VN, Charland SL, Oderda GM, Brixner DI. LaFleur J, et al. Among authors: oderda gm. Ann Pharmacother. 2006 Jul-Aug;40(7-8):1274-9. doi: 10.1345/aph.1G646. Epub 2006 Jul 18. Ann Pharmacother. 2006. PMID: 16849622

7

Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.

Biskupiak JE, Brixner DI, Howard K, Oderda GM. Biskupiak JE, et al. Among authors: oderda gm. J Pain Palliat Care Pharmacother. 2006;20(3):7-14. J Pain Palliat Care Pharmacother. 2006. PMID: 16931473

8

Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.

Creekmore FM, Oderda GM, Pendleton RC, Brixner DI. Creekmore FM, et al. Among authors: oderda gm. Pharmacotherapy. 2006 Oct;26(10):1438-45. doi: 10.1592/phco.26.10.1438. Pharmacotherapy. 2006. PMID: 16999654

9

Evaluation of cardiovascular risk factors, events, and costs across four BMI categories.

Brixner DI, Bron M, Bellows BK, Ye X, Yu J, Raparla S, Oderda GM. Brixner DI, et al. Among authors: oderda gm. Obesity (Silver Spring). 2013 Jun;21(6):1284-92. doi: 10.1002/oby.20215. Obesity (Silver Spring). 2013. PMID: 23913737 Free article.

10

Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer.

Mistry R, Suri G, Young K, Hettle R, May JR, Brixner D, Oderda G, Biskupiak J, Tang D, Bhattacharyya D, Bhattacharyya S, Mishra D, Dalal AA. Mistry R, et al. Curr Med Res Opin. 2018 Dec;34(12):2143-2150. doi: 10.1080/03007995.2018.1503484. Epub 2018 Aug 17. Curr Med Res Opin. 2018. PMID: 30032697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page